These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 6001331)
21. ON THE ROLE OF THE C-TERMINAL TYROSINE RESIDUES OF ALDOLASE. WU CY; SHI WQ Sci Sin; 1964 Mar; 13():459-62. PubMed ID: 14153131 [No Abstract] [Full Text] [Related]
22. Antibody-catalyzed benzoin oxidation as a mechanistic probe for nucleophilic catalysis by an active site lysine. Sklute G; Oizerowich R; Shulman H; Keinan E Chemistry; 2004 May; 10(9):2159-65. PubMed ID: 15112204 [TBL] [Abstract][Full Text] [Related]
23. [Various aspects of structure-activity relations of alicyclic amines]. Gandini A Farmaco Sci; 1967 Mar; 22(3):210-24. PubMed ID: 4388810 [No Abstract] [Full Text] [Related]
24. Hydroxynaphthaldehyde phosphate derivatives as potent covalent Schiff base inhibitors of fructose-1,6-bisphosphate aldolase. Dax C; Coinçon M; Sygusch J; Blonski C Biochemistry; 2005 Apr; 44(14):5430-43. PubMed ID: 15807536 [TBL] [Abstract][Full Text] [Related]
25. THE MECHANISM OF ACTION OF ADLOLASES. V. INACTIVATION OF FLUORO- AND CHLORODINITROBENZENE. ROWLEY PT; TCHOLA O; HORECKER BL Arch Biochem Biophys; 1964 Aug; 107():305-12. PubMed ID: 14224838 [No Abstract] [Full Text] [Related]
26. Properties of fructose-1,6-bisphosphate aldolase from Escherichia coli: an NMR analysis. Szwergold BS; Ugurbil K; Brown TR Arch Biochem Biophys; 1995 Feb; 317(1):244-52. PubMed ID: 7872790 [TBL] [Abstract][Full Text] [Related]
27. Brownian dynamics of interactions between aldolase mutants and F-actin. Lowe SL; Atkinson DM; Waingeh VF; Thomasson KA J Mol Recognit; 2002; 15(6):423-31. PubMed ID: 12501161 [TBL] [Abstract][Full Text] [Related]
28. Graphical and weighted regression analyses for the determination of agonist dissociation constants. Thron CD J Pharmacol Exp Ther; 1970 Nov; 175(2):541-53. PubMed ID: 5481719 [No Abstract] [Full Text] [Related]
29. Reactions of sulfenes with ketene acetals and ketene animals. Truce WE; Abraham DJ; Son P J Org Chem; 1967 Apr; 32(4):990-7. PubMed ID: 6042165 [No Abstract] [Full Text] [Related]
30. Studies on ketene and its derivatives. X. Reaction of diketene with Schiff base. Kato T; Yamamoto Y Chem Pharm Bull (Tokyo); 1965 Aug; 13(8):959-62. PubMed ID: 5867838 [No Abstract] [Full Text] [Related]
33. Thalidomide as a possible biological acylating agent. Fabro S; Smith RL; Williams RT Nature; 1965 Dec; 208(5016):1208-9. PubMed ID: 5870320 [No Abstract] [Full Text] [Related]
34. [Characteristics of substrates of aldolase reaction and tentative models of aldolase]. Mel'nichenko IV; Kozlova NIa; Iasnikov AA Biokhimiia; 1969; 34(4):699-705. PubMed ID: 5358501 [No Abstract] [Full Text] [Related]
35. THE MECHANISM OF ACTION OF ALDOLASES. IV. LYSINE AS THE SUBSTRATE-BINDING SITE. HORECKER BL; ROWLEY PT; GRAZI E; CHENG T; TCHOLA O Biochem Z; 1963; 338():36-51. PubMed ID: 14087308 [No Abstract] [Full Text] [Related]
36. The mechanism of action of AET. VI. The protection of proteins against ionizing radiation by GED. Kollmann G; Shapiro B Radiat Res; 1966 Mar; 27(3):474-86. PubMed ID: 5931439 [No Abstract] [Full Text] [Related]
37. [On the mechanism of aldolase action]. Iasnikov AA; Boĭko TS; Volkova NV; Mel'nichenko IV Biokhimiia; 1966; 31(5):969-75. PubMed ID: 6001331 [No Abstract] [Full Text] [Related]
38. Carbanion intermediates in the reaction of yeast and muscle aldolase. Riordan JF; Christen P Biochemistry; 1969 Jun; 8(6):2381-6. PubMed ID: 5799131 [No Abstract] [Full Text] [Related]